Protease inhibitor infusion improves survival rate and hemodynamics in experimental pancreatic shock.
D000208:Acute Disease; D000818:Animals; D007611:Aprotinin / Q000378:metabolism / Q000494:pharmacology*; D001202:Ascitic Fluid / Q000378:metabolism*; D003174:Complement C1 Inactivator Proteins / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D007610:Kallikreins / Q000037:antagonists & inhibitors / Q000378:metabolism; D010195:Pancreatitis / Q000378:metabolism / Q000503:physiopathology*; D011288:Prekallikrein / Q000378:metabolism; D012769:Shock / Q000378:metabolism / Q000503:physiopathology*; D013552:Swine
D003174:Complement C1 Inactivator Proteins; D011288:Prekallikrein; D007611:Aprotinin; D007610:Kallikreins